SOURCE: Anti-Aging Medical Group Corp

June 13, 2006 09:00 ET

Anti-Aging Medical Group Enters Multi Billion Dollar Heart Health Market With New Product LipoBloc

TORONTO -- (MARKET WIRE) -- June 13, 2006 -- Anti-Aging Medical Group Corp. (PINKSHEETS: AAGM), a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits, announces that they are entering into the multi billion dollar a year heart health market.

"We are very excited about the prospects of LipoBloc, in keeping with our belief of providing products that make one look and feel younger. LipoBloc is a great addition to the AAGM product line. The Heart Health market is a large multi billion dollar market where new products are always embraced immediately and we feel LipoBloc will have an impact in that market," says Rita Sung, CEO.

Introducing LipoBloc®

Natural plant extracts known as "phytosterols" have been proven in numerous clinical studies since the 1950s to reduce serum cholesterol. More recent research has shown that the unique formulation of "solubilized phytosterols" in LipoBloc produce higher reductions in total serum cholesterol, LDL (the "bad" or "Lousy") cholesterol and more significant increases in the ratio of HDL (the "good" or "Healthy") cholesterol to total cholesterol. Unlike conventional products, LipoBloc phytosterols are 100% dispersed in the gastrointestinal fluid and more effectively block the direct absorption of cholesterol and the reabsorption of bile acids from the intestinal tract, which form cholesterol in the body.

The LipoBloc Difference

LipoBloc makes the difference in cholesterol management with a unique proprietary delivery matrix which completely solubilizes phytosterols in the body for efficient absorption. LipoBloc also contains "polycosanol," a natural substance found in many plants and whole grains, which has also been shown to lower LDL while raising HDL cholesterol levels.

About Anti-Aging Medical Group Corp.

We are a specialty pharmaceutical company focused on developing, acquiring and commercializing innovative and scientifically proven products that offer both health maintenance and appearance enhancing benefits to all of us. We here at Anti-Aging Medical Group Corporation call this Nutraceuticals and Cosmeceuticals. Nutraceuticals are products that have multiple benefits in terms of revitalization for vision, prostate, bone and joint care as well as memory improvement. At Anti-Aging Medical Group Corporation, we are developing a drug delivery based, proprietary, non-prescription topical and oral product line, which is fast becoming the industry's leader in the treatment of age resistance. Cosmeceuticals -- are skin care products which are specifically designed to enhance the appearance of your skin while catering to its needs.

Anti-Aging Medical Group Corporation is developing a drug delivery based, proprietary skin care product line, which falls under our Cosmeceuticals product line. Cosmeceuticals will not only reduce the signs of aging but they also provide significant skin care benefits. They serve to enhance skin appearance and reduce signs of aging. For more information about us please visit our website at www.anti-agingmedical.net.

FORWARD-LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company. These statements describe management's current beliefs and expectations concerning the future of Anti-Aging Medical Corp. These forward-looking statements are identified by using words such as "expect," "believe," and "should." Although the beliefs and expectations mentioned in this release are reasonable, the Company's operations involve a number of risks and uncertainties. Therefore, these statements may turn out not to be true. The Company will not update forward-looking statements in this news release to reflect actual results, changes in assumptions, or changes in other factors affecting such forward-looking information.

Note: The FDA has not evaluated these statements. This statement is not intended to diagnose, treat, cure or prevent disease.

Contact Information